149 related articles for article (PubMed ID: 5420103)
1. Drug-induced inhibition of tumour cell dissemination.
Burrage K; Hellmann K; Salsbury AJ
Br J Pharmacol; 1970 May; 39(1):205P-206P. PubMed ID: 5420103
[No Abstract] [Full Text] [Related]
2. Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane.
Salsbury AJ; Burrage K; Hellmann K
Cancer Res; 1974 Apr; 34(4):843-9. PubMed ID: 4814997
[No Abstract] [Full Text] [Related]
3. Vascular changes in tumours after treatment with ICRF 159.
Le Serve AW; Hellmann K
Br J Pharmacol; 1971 Oct; 43(2):457P-458P. PubMed ID: 5158233
[No Abstract] [Full Text] [Related]
4. Rotational stress reduces the effectiveness of antitumor drugs in mice.
Giraldi T; Perissin L; Zorzet S; Rapozzi V
Ann N Y Acad Sci; 1994 Nov; 741():234-43. PubMed ID: 7825811
[No Abstract] [Full Text] [Related]
5. The influence of zinc status on the anti-Lewis lung tumour activity of cisplatin and gallium.
Capel ID; Dorrell HM; Pinnock MH; Jenner M; Williams DC
Anticancer Res; 1981; 1(5):269-73. PubMed ID: 7201776
[TBL] [Abstract][Full Text] [Related]
6. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of metastatic spread by I.C.R.F. 159: selective deletion of a malignant characteristic.
Salsbury AJ; Burrage K; Hellmann K
Br Med J; 1970 Nov; 4(5731):344-6. PubMed ID: 5528754
[TBL] [Abstract][Full Text] [Related]
8. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
[TBL] [Abstract][Full Text] [Related]
9. A quantitative model for the study of the growth and treatment of a tumor and its metastases with correlation between proliferative state and sensitivity to cyclophosphamide.
DeWys WD
Cancer Res; 1972 Feb; 32(2):367-73. PubMed ID: 5058192
[No Abstract] [Full Text] [Related]
10. Pulmonary metastases of the lewis lung tumor-cell kinetics and response to cyclophosphamide at different sizes.
Hill RP; Stanley JA
Cancer Treat Rep; 1977; 61(1):29-36. PubMed ID: 861961
[TBL] [Abstract][Full Text] [Related]
11. Effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane on tumor blood vessels and its relationship to the antimetastatic effect in the Lewis lung carcinoma.
James SE; Salsbury AJ
Cancer Res; 1974 Apr; 34(4):839-42. PubMed ID: 4814996
[No Abstract] [Full Text] [Related]
12. [Effects of bimolane on size, metastases and cyclic AMP levels of Lewis lung carcinoma].
Huang KW; Fu NW; Ren YF
Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):69-71. PubMed ID: 6326466
[No Abstract] [Full Text] [Related]
13. Inhibition of growth of primary and metastatic Lewis lung carcinoma cells by the phosphodiesterase inhibitor isobutylmethylxanthine.
Janik P; Assaf A; Bertram JS
Cancer Res; 1980 Jun; 40(6):1950-4. PubMed ID: 6154533
[No Abstract] [Full Text] [Related]
14. Evaluation of surgery, chemotherapy and immunotherapy on Lewis lung tumour.
Thompson RB; Alberola V; Mathé G
Rev Eur Etud Clin Biol; 1972 Nov; 17(9):900-2. PubMed ID: 4653992
[No Abstract] [Full Text] [Related]
15. Experimental studies on the spread of cancer, with special reference to fibrinolytic agents and anticoagulants.
Wood S
J Med; 1974; 5(1):7-22. PubMed ID: 4134042
[No Abstract] [Full Text] [Related]
16. Proliferative character and growth modes of neoplastic disease as determinants of chemotherapeutic efficacy.
Schenken LL
Cancer Treat Rep; 1976 Dec; 60(12):1761-76. PubMed ID: 829040
[No Abstract] [Full Text] [Related]
17. [Trial of chemotherapy on cancer dissemination and metastasis].
Franchi G; Donelli MG; Rosso R
Rev Eur Etud Clin Biol; 1970 Apr; 15(4):453-9. PubMed ID: 5421871
[No Abstract] [Full Text] [Related]
18. Inhibition of urethan induced lung tumour growth in strain A mice by 5-methyl cytidine.
Theiss JC
Cytobios; 1980; 29(115-116):159-63. PubMed ID: 7471817
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model.
Sigounas G; Sallah S; Sigounas VY
Cancer Lett; 2004 Oct; 214(2):171-9. PubMed ID: 15363543
[TBL] [Abstract][Full Text] [Related]
20. [Principles of adjuvant cytostatic therapy].
Schreml W
Aktuelle Probl Chir Orthop; 1982; 22():10-7. PubMed ID: 6121507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
